- Home
- CYRX
CYRX
CryoPort Inc.
as 05-30-2025 4:00pm EST
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | BRENTWOOD |
| Market Cap: | 277.5M | IPO Year: | N/A |
| Target Price: | $10.75 | AVG Volume (30 days): | 449.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.58 - $11.64 | Next Earning Date: | 05-07-2025 |
| Revenue: | $232,134,000 | Revenue Growth: | 11.75% |
| Revenue Growth (this year): | -20.04% | Revenue Growth (next year): | 9.41% |
Stock Insider Trading Activity of CryoPort Inc. (CYRX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| STEFANOVICH ROBERT | CYRX | Chief Financial Officer | Mar 24 '25 | Sell | $6.94 | 1,070 | $7,427.51 | 190,349 | |
| Sawicki Mark W | CYRX | Chief Scientific Officer | Mar 24 '25 | Sell | $6.94 | 1,349 | $9,364.22 | 84,087 | |
| SHELTON JERRELL | CYRX | President, CEO | Mar 24 '25 | Sell | $6.94 | 2,980 | $20,685.97 | 762,419 | |
| STEFANOVICH ROBERT | CYRX | Chief Financial Officer | Mar 14 '25 | Sell | $6.29 | 1,659 | $10,437.93 | 190,349 | |
| Sawicki Mark W | CYRX | Chief Scientific Officer | Mar 14 '25 | Sell | $6.29 | 2,092 | $13,162.24 | 84,087 | |
| SHELTON JERRELL | CYRX | President, CEO | Mar 14 '25 | Sell | $6.29 | 4,620 | $29,067.65 | 762,419 | |
| ZECCHINI EDWARD J | CYRX | Chief Digital and Tech Officer | Mar 14 '25 | Sell | $6.29 | 1,140 | $7,172.54 | 66,911 | |
| STEFANOVICH ROBERT | CYRX | Chief Financial Officer | Mar 9 '25 | Sell | $4.88 | 1,256 | $6,128.15 | 190,349 | |
| Sawicki Mark W | CYRX | Chief Scientific Officer | Mar 9 '25 | Sell | $4.88 | 1,583 | $7,723.62 | 84,087 | |
| SHELTON JERRELL | CYRX | President, CEO | Mar 9 '25 | Sell | $4.88 | 4,173 | $20,360.48 | 762,419 |
Latest CryoPort Inc. News
CYRX Breaking Stock News: Dive into CYRX Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
Wall Street Analysts Believe CryoPort (CYRX) Could Rally 81.43%: Here's is How to Trade
Zacks
20 days ago
Does CryoPort (CYRX) Have the Potential to Rally 54.74% as Wall Street Analysts Expect?
Simply Wall St.
22 days ago
Cryoport First Quarter 2025 Earnings: Beats Expectations
GuruFocus.com
24 days ago
CryoPort Inc (CYRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Zacks
25 days ago
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
PR Newswire
25 days ago
Cryoport Reports First Quarter 2025 Financial Results
Zacks
a month ago
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy?
PR Newswire
a month ago
Cryoport to Report First Quarter 2025 Financial Results on May 7, 2025
Compare CYRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CYRX CryoPort Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.